These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 3152912)
1. Action of intermediate doses of methotrexate on dihydrofolate reductase in malignant diseases. Tzortzatou-Stathopoulou F; Zavitsa-Pateli H; Mousatos G; Prodromou N; Kairis M; Pappas J Pediatr Hematol Oncol; 1987; 4(1):43-53. PubMed ID: 3152912 [TBL] [Abstract][Full Text] [Related]
2. Biochemical factors in the selectivity of leucovorin rescue: selective inhibition of leucovorin reactivation of dihydrofolate reductase and leucovorin utilization in purine and pyrimidine biosynthesis by methotrexate and dihydrofolate polyglutamates. Goldman ID; Matherly LH NCI Monogr; 1987; (5):17-26. PubMed ID: 2448654 [TBL] [Abstract][Full Text] [Related]
3. High-performance liquid chromatographic and enzyme-inhibition assays of methotrexate concentrations in serum from patients receiving high-dose therapy: tight binding of some methotrexate to a protein that could be dihydrofolate reductase. Iven H; Bartels H Cancer Treat Rep; 1985; 69(7-8):825-32. PubMed ID: 4016793 [TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of resistance to antifolates, a review. Banerjee D; Ercikan-Abali E; Waltham M; Schnieders B; Hochhauser D; Li WW; Fan J; Gorlick R; Goker E; Bertino JR Acta Biochim Pol; 1995; 42(4):457-64. PubMed ID: 8852336 [TBL] [Abstract][Full Text] [Related]
5. Much more than you expected: The non-DHFR-mediated effects of methotrexate. Sramek M; Neradil J; Veselska R Biochim Biophys Acta Gen Subj; 2017 Mar; 1861(3):499-503. PubMed ID: 27993660 [TBL] [Abstract][Full Text] [Related]
6. Further studies on the pharmacologic effects of the 7-hydroxy catabolite of methotrexate in the L1210 murine leukemia cell. Seither RL; Rape TJ; Goldman ID Biochem Pharmacol; 1989 Mar; 38(5):815-22. PubMed ID: 2467676 [TBL] [Abstract][Full Text] [Related]
7. Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells. Chen G; Wright JE; Rosowsky A Mol Pharmacol; 1995 Oct; 48(4):758-65. PubMed ID: 7476904 [TBL] [Abstract][Full Text] [Related]
8. Establishment of dihydrofolate reductase-increased human cell lines and relationship between dihydrofolate reductase levels and gene copy. Domin BA; Grill SP; Cheng Y Cancer Res; 1983 May; 43(5):2155-8. PubMed ID: 6831441 [TBL] [Abstract][Full Text] [Related]
9. Transgenic mice expressing the tyr22 variant of murine DHFR: protection of transgenic marrow transplant recipients from lethal doses of methotrexate. James RI; May C; Vagt MD; Studebaker R; McIvor RS Exp Hematol; 1997 Nov; 25(12):1286-95. PubMed ID: 9357973 [TBL] [Abstract][Full Text] [Related]
11. Methotrexate-based PROTACs as DHFR-specific chemical probes. Rana S; Dranchak P; Dahlin JL; Lamy L; Li W; Oliphant E; Shrimp JH; Rajacharya GH; Tharakan R; Holland DO; Whitten AS; Wilson KM; Singh PK; Durum SK; Tao D; Rai G; Inglese J Cell Chem Biol; 2024 Feb; 31(2):221-233.e14. PubMed ID: 37875111 [TBL] [Abstract][Full Text] [Related]
12. Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase. Jolivet J; Chabner BA J Clin Invest; 1983 Sep; 72(3):773-8. PubMed ID: 6193143 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemistry of dihydrofolate reductase in methotrexate-sensitive and -resistant human cell lines by flow cytometry: a comparison with the cytochemical tetrazolium salt method. Nano R; Gerzeli G; Morandi C; Arisi C Acta Histochem; 1992; 93(1):290-7. PubMed ID: 1529671 [TBL] [Abstract][Full Text] [Related]
14. Investigation on inhibitory effect of folic acid on methotrexate-induced epithelial-mesenchymal transition focusing on dihydrofolate reductase. Kawami M; Honda N; Hara T; Yumoto R; Takano M Drug Metab Pharmacokinet; 2019 Dec; 34(6):396-399. PubMed ID: 31601464 [TBL] [Abstract][Full Text] [Related]